Skip to main content
Fig. 5 | Journal of Nanobiotechnology

Fig. 5

From: Nanobiotechnology approaches for cardiovascular diseases: site-specific targeting of drugs and nanoparticles for atherothrombosis

Fig. 5

Representative images of 3D ultrasound reconstructions of abdominal aorta, photographs of vessel isolations, immunohistochemistry, and Martius Scarlet Blue demonstrating profound effect of VCAM-1–targeted miR-carrying microbubbles. A 3D ultrasound reconstruction of abdominal aorta shows vessel lumen (in red), as well as massive areas of plaque build-up and aneurysm (in blue), from animals treated with TargMB-A126 or TargMB-S126 but not in animals treated with TargMB-M126. B Vessel isolation shows clean abdominal aorta in mice treated with TargMB-M126 but plaque build-up and aneurysms in mice given TargMB-S126 or TargMB-A126. C Immunohistochemistry confirmed a decrease in VCAM-1 expression for TargMB-M126 treated animals as compared to those treated with TargMB-A126 or TargMB-S126. D Martius Scarlet Blue showed plaque build-up and aneurysms in abdominal arteries of TargMB-A126 or TargMB-S126 treated animals, whereas very little plaque build-up was observed in TargMB-M126 treated mice [63]

Back to article page